Views of Ms. Sarabjit Kour Nangra (VP Research- Pharma, Angel Broking):
"Dr Reddy's Laboratories Ltd and Integra LifeSciences Holdings Corporation, a global medical Technology company, have entered into an exclusive distribution agreement. Under the agreement, will market and distribute DuraGen Plus and Suturable DuraGen Dural Regeneration Matrices for use in patients in India. With the launch of DuraGen, the company is looking forward to building its presence in the segment of regenerative technologies and making a difference to the lives of patients undergoing neurosurgery. Integra's DuraGen products have been implanted in more than 1.8mn patients worldwide to effect dural closure following neurosurgical procedures. Integra manufactures the DuraGen family of products based on its proprietary Ultra Pure Collagen technology platform. The pact will further strengthen the domestic offerings of Dr Reddy's Lab in India. We maintain our NEUTRAL view on the stock."
Shares of DR.REDDY'S LABORATORIES LTD. was last trading in BSE at Rs.2635.85 as compared to the previous close of Rs. 2638.65. The total number of shares traded during the day was 17991 in over 1579 trades.
The stock hit an intraday high of Rs. 2648.05 and intraday low of 2626.15. The net turnover during the day was Rs. 47453177.